What is the difference between talazoparib/talazoparib and talazoparib? Comparison of drug ingredients and effects
Talazoparib, talazoparib and Talazoparib actually refer to the same drug, but they have different translation names during the Chinese translation process. Among them, "Talazoparib" is its international common name (INN), while "talazoparib" and "talazoparib" are transliterations of Talazoparib based on Chinese pronunciation habits. There is no essential difference between the two in terms of composition, structure and therapeutic effect. This phenomenon is relatively common in the process of internationalization of drug names. Different regions may use slightly different translations, but they all refer to the same drug.
Talazoparib is an oralPARP (polyadenosine diphosphate-ribose polymerase) inhibitor. It is mainly used to treat advanced or metastatic breast cancer with BRCA1 or BRCA2 gene mutations. It is also being studied for use in various tumors such as ovarian cancer, pancreatic cancer and prostate cancer. Its mechanism of action is by inhibiting theDNA repair pathway, making it difficult for tumor cells to repair DNA damage, thereby inducing cell apoptosis.

From a formulation perspective, whether it is called talazoparib, talazoparib or Talazoparib, as long as it is an original drug produced by the same manufacturer (such as Pfizer), its drug content, formulation process and efficacy are completely the same. In terms of clinical efficacy and safety, the original drug has been verified through rigorous multi-center clinical trials and is widely considered to have significant advantages in the treatment of BRCA mutation-related cancers. On the premise that generic drugs meet bioequivalence requirements, their ingredients are the same as the original drugs. However, there may be slight differences in the excipients and preparation processes used by different manufacturers, which may lead to slightly different absorption rates, but usually do not affect the overall efficacy.
To sum up, patients do not need to be confused by the differences in the translation names of "talazoparib" and "talazoparib" when choosing a drug. The key is to clarify the international generic name of the drug, Talazoparib, and whether its source is the original drug or a officially registered generic drug.
Reference materials:https://www.talzenna.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)